D&D Pharmatech (347850.KQ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−91.9x

Market Cap

KRW 2.83T

MomentumView details →

1D Return

−1.12%

YTD Return

−46.41%

RSI (14)

37.7

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−91.9x

Market Cap

KRW 2.83T

RSI (14)

37.7

MomentumView details →

1D Return

−1.12%

YTD Return

−46.41%

ProfitabilityView details →

Gross Margin

−56.61%

Net Margin

−785.51%

EBITDA Margin

−1103.01%

ROE (TTM)

−16.04%

ROA (TTM)

−6.75%

Asset Turnover

0.01x

GrowthView details →

Revenue YoY

−70.53%

EPS YoY

+42.61%

FCF YoY

+7.45%

Revenue CAGR 3Y

+91.65%

EPS CAGR 3Y

+22.49%

EBITDA YoY

−42.78%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.85x

Current Ratio

27.21x

Quick Ratio

27.21x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

2.75B

Net Income (TTM)

−21.60B

Op. CF (TTM)

−24.89B

Latest newsMore news →

No recent news for 347850.KQ.

Similar companies

Voronoi, Inc.310210.KQ SK bioscience Co.,Ltd.302440.KS Hugel, Inc.145020.KQ LigaChem Biosciences Inc.141080.KQ Peptron, Inc.087010.KQ PharmaResearch Co., Ltd.214450.KQ Find similar companies →

Latest newsMore news →

No recent news for 347850.KQ.